This Week's Poll

At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you

Supported by Medilink UK

Patent Box in 2011 - Les Farrington of - Binding Site - 10:17:36am Feb-19th

The introduction of the 10% Patent Box is welcome news for companies such as mine who are investing heavily in R&D. It also supports the concept of keeping the innovation in the UK. The only real concern we have about this scheme is waiting until 2011, especially after the successful drive of the Office of Life Science and their recent launch to deliver the blueprint- what’s the rational and where’s the investment short term?

Agree/Disagree + add comment

Andrew Ives of - ATM - 16:53:25pm Feb-22nd

What a wonderful scheme. By announcing now and delaying until after the electionthe government grabs the credit and leaves another to pick up the tab......again. SMEs need help now to file and support patents otherwise there will be no income on which the tax relief can be claimed.

 
 
t